Survival in glioblastoma: a review on the impact of treatment modalities, Clin Transl Oncol, vol.18, pp.1062-71, 2016. ,
, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, pp.987-96, 2005.
Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis, World Neurosurg, vol.92, pp.197-205, 2016. ,
Identification of human brain tumour initiating cells, Nature, vol.432, pp.396-401, 2004. ,
Cancer stem cells in glioblastoma, Genes Dev, vol.29, pp.1203-1220, 2015. ,
Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma, Stem Cells Dev, vol.16, pp.837-884, 2007. ,
Radiation resistance of cancer stem cells: the 4 ,
, R's of radiobiology revisited, Stem Cells, vol.28, pp.639-687, 2010.
Chemoresistance of glioblastoma cancer stem cells--much more complex than expected, Mol Cancer, vol.10, p.128, 2011. ,
Notch promotes radioresistance of glioma stem cells, Stem Cells, vol.28, pp.17-28, 2010. ,
, Connexin, vol.43
, Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide, Cancer Res, vol.76, pp.139-188, 2016.
, Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma, Cancer Cell, vol.24, pp.331-377, 2013.
Current medical treatment of glioblastoma, Cancer Treat Res, vol.163, pp.103-118, 2015. ,
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma, J Neurooncol, vol.96, pp.219-249, 2010. ,
Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III, Cancer Res, vol.74, pp.1238-1287, 2014. ,
HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors, Clin Cancer Res, vol.16, pp.474-85, 2010. ,
Stem-like tumor-initiating cells isolated from IL13Ralpha2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells, Clin Cancer Res, vol.18, pp.2199-209, 2012. ,
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma, Mol Ther, vol.21, pp.2087-101, 2013. ,
Tandem CAR T cells targeting HER2 and IL13Ralpha2 mitigate tumor antigen escape, J Clin Invest, vol.126, pp.3036-52, 2016. ,
EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma, Sci Transl Med, vol.9, 2017. ,
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside, Oncotarget, vol.7, pp.41172-85, 2016.,
URL : https://hal.archives-ouvertes.fr/inserm-01319327
Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside, Oncoimmunology, vol.7, p.1373232, 2017.,
URL : https://hal.archives-ouvertes.fr/inserm-01596068
Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity, Proc Natl Acad Sci U S A, vol.113, pp.5592-5599, 2016. ,
Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity, Clin Cancer Res, vol.23, pp.6292-304, 2017.,
URL : https://hal.archives-ouvertes.fr/inserm-01595798
Rapid colorimetric assay for cell growth and survival ,
, Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability, J Immunol Methods, vol.89, pp.271-278, 1986.
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv Enzyme Regul, vol.22, pp.27-55, 1984. ,
, Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of
, Antibody-drug Synergism Using the Combination Index Equation, J Vis Exp, 2019.
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J Immunol Methods, vol.347, pp.70-78, 2009. ,
, methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide, Clin Cancer Res, vol.10, pp.1871-1875, 2004.
Mitotic arrest, apoptosis, and sensitization to chemotherapy of melanomas by methionine deprivation stress, Mol Cancer Res, vol.4, pp.575-89, 2006. ,
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity, Front Oncol, vol.6, p.55, 2011. ,
Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date, Cancer, vol.121, pp.502-518, 2015. ,
, Identification of a cancer stem cell in human brain tumors, Cancer Res, vol.63, pp.5821-5829, 2003.
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity, Stem Cells, vol.27, pp.40-48, 2009. ,
Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis, J Exp Clin Cancer Res, vol.34, p.44, 2015. ,
, Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials, Cancer Treat Rev, vol.23, pp.35-61, 1997.
The process of subretinal strand formation, Jpn J Ophthalmol, vol.36, pp.222-256, 1992. ,
Detection of histone H2AX ,
, phosphorylation on Ser-139 as an indicator of DNA damage (DNA double-strand breaks)
, This article is protected by copyright. All rights reserved, Curr Protoc Cytom, vol.7, p.27, 2004.
Stereotaxic administrations of allogeneic human Vgamma9Vdelta2 T cells efficiently control the development of human glioblastoma brain tumors, Oncoimmunology, vol.5, p.1168554, 2016. ,
A comparative study of the pathogenesis of western equine and eastern equine encephalomyelitis viral infections in mice by intracerebral and subcutaneous inoculations, J Infect Dis, vol.122, pp.53-63, 1970. ,
A simple practice guide for dose conversion between animals and human, J Basic Clin Pharm, vol.7, pp.27-31, 2016. ,
Stem cells, cancer, and cancer stem cells, Nature, vol.414, pp.105-116, 2001. ,
D2) loss following monoclonal antibody therapy is rare in neuroblastoma, Clin Cancer Res, vol.4, pp.2135-2144, 1998. ,
Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy, J Neurol Sci, vol.149, pp.127-157, 1997. ,
Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies, Cell Biochem Funct, vol.28, pp.343-51, 2010. ,
131-I coupled to monoclonal antibodies as therapeutic agents for neuroectodermally derived tumors: fact or fiction?, Cancer Drug Deliv, vol.3, pp.25-43, 1986. ,
Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy, Cell Death Differ, vol.21, pp.1119-1150, 2014. ,
Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma, Cancer Immunol Immunother, vol.44, pp.157-64, 1997. ,